Home
Resources
Diseases
Compendium
Training
Evaluation
The Tool
The Tutorial
SYSVAC
About
Registry
E-learning courses
News
Webinars
Network
Steering Committee
Vision and Mission
Map
Meetings
Partners
Join us
Home
Resources
Resources
Type of publications
Guidelines (30)
NITAG documentation (1591)
Reports (55)
SAGE documentation (218)
Scientific publications (112)
Systematic reviews (SYSVAC) (2750)
Regions
Africa (267)
Americas (762)
Eastern Mediterranean (48)
Europe (704)
South-East Asia (78)
Western Pacific (196)
Diseases
Chikungunya (9)
Cholera (33)
COVID-19 (1481)
Cytomegalovirus (1)
Dengue (39)
Diphtheria (79)
Ebola (16)
Escherichia coli (ETEC) (2)
Haemophilus influenzae type B (66)
Hepatitis A (63)
Hepatitis B (153)
Hepatitis C (4)
Hepatitis E (5)
Herpes simplex (1)
Herpes zoster (66)
HIV / AIDS (10)
Human papillomavirus (HPV) (472)
Influenza (573)
Japanese encephalitis (34)
Lyme disease, Borreliosis (1)
Malaria (27)
Measles (128)
Meningococcal disease (145)
Mpox (55)
Mumps (46)
Pertussis (104)
Pneumococcal disease (266)
Poliomyelitis (84)
Q fever (1)
Rabies (28)
Rotavirus (115)
RSV (Respiratory syncytial virus) (47)
Rubella (64)
Salmonella (2)
Shigella (1)
Smallpox (16)
Streptococcus group B (6)
Tetanus (59)
Tick-borne encephalitis (12)
Tuberculosis (73)
Typhoid (23)
Varicella (69)
Yellow fever (42)
Zika (1)
Show more
4756 results found
2023
∙
JCVI
JCVI statement on the COVID-19 vaccination programme for autumn 2023 - updated on October 2023
2023
∙
CoPI
Recommendation on the use of a single dose of the Human Papillomavirus (HPV) vaccine
2023
∙
CoPI
Recommendation on preventive use of the cholera vaccine
2023
∙
CoPI
Recommendation for Measles and Rubella vaccination campaign
2023
Off-label vaccine use: explanatory note for countries
2023
∙
Matthew Tunis, Shelley Deeks, Caroline Quach, Marina Salvadori, Bryna Warshawsky, Kelsey Young, Shainoor Ismail, Christine Mauviel, Erin Henry
Canada’s National Advisory Committee on immunization: Adaptations and challenges during the COVID-19 pandemic
2023
Vaccination recommendations against flu and COVID-19 in the 2023-2024 season in Spain. Update.
2023
∙
CAVEI
CAVEI recommendation on incorporation of a monoclonal antibody for passive immunization against respiratory syncytial virus in infants in the Program National Immunization
2023
∙
CAVEI
CAVEI RECOMMENDATION ON VACCINATION INCORPORATION AGAINST RESPIRATORY SYNCYCIAL VIRUS IN OLDER ADULTS AND PREGNANT WOMEN IN THE NATIONAL IMMUNIZATION PROGRAM
2023
∙
CAVEI
update of the CAVEI recommendation on vaccination against HPV
Home
Resources
Diseases
Compendium
Training
Evaluation
SYSVAC
News
Webinars
Network
Sign in / Register